chr5-141573692-G-A

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_005219.5(DIAPH1):​c.2158C>T​(p.Leu720Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000093 in 1,602,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00040 ( 0 hom., cov: 27)
Exomes 𝑓: 0.000061 ( 0 hom. )

Consequence

DIAPH1
NM_005219.5 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.972

Publications

2 publications found
Variant links:
Genes affected
DIAPH1 (HGNC:2876): (diaphanous related formin 1) This gene is a homolog of the Drosophila diaphanous gene, and has been linked to autosomal dominant, fully penetrant, nonsyndromic sensorineural progressive low-frequency hearing loss. Actin polymerization involves proteins known to interact with diaphanous protein in Drosophila and mouse. It has therefore been speculated that this gene may have a role in the regulation of actin polymerization in hair cells of the inner ear. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
DIAPH1 Gene-Disease associations (from GenCC):
  • DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • autosomal dominant nonsyndromic hearing loss 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • progressive microcephaly-seizures-cortical blindness-developmental delay syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03889391).
BP6
Variant 5-141573692-G-A is Benign according to our data. Variant chr5-141573692-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 450432.We mark this variant Benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=4}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIAPH1NM_005219.5 linkc.2158C>T p.Leu720Phe missense_variant Exon 16 of 28 ENST00000389054.8 NP_005210.3 O60610-1Q6URC4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIAPH1ENST00000389054.8 linkc.2158C>T p.Leu720Phe missense_variant Exon 16 of 28 5 NM_005219.5 ENSP00000373706.4 O60610-1
DIAPH1ENST00000518047.5 linkc.2131C>T p.Leu711Phe missense_variant Exon 15 of 27 5 ENSP00000428268.2 O60610-3
DIAPH1ENST00000647433.1 linkc.2158C>T p.Leu720Phe missense_variant Exon 16 of 29 ENSP00000494675.1 A0A2R8Y5N1

Frequencies

GnomAD3 genomes
AF:
0.000398
AC:
60
AN:
150856
Hom.:
0
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.00117
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000594
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.000484
GnomAD2 exomes
AF:
0.000125
AC:
30
AN:
239424
AF XY:
0.0000692
show subpopulations
Gnomad AFR exome
AF:
0.000950
Gnomad AMR exome
AF:
0.000242
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000464
Gnomad OTH exome
AF:
0.000510
GnomAD4 exome
AF:
0.0000606
AC:
88
AN:
1451106
Hom.:
0
Cov.:
38
AF XY:
0.0000583
AC XY:
42
AN XY:
720510
show subpopulations
African (AFR)
AF:
0.000782
AC:
26
AN:
33262
American (AMR)
AF:
0.000345
AC:
15
AN:
43512
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25740
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39484
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85768
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53164
Middle Eastern (MID)
AF:
0.00105
AC:
6
AN:
5732
European-Non Finnish (NFE)
AF:
0.0000226
AC:
25
AN:
1104522
Other (OTH)
AF:
0.000250
AC:
15
AN:
59922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000404
AC:
61
AN:
150976
Hom.:
0
Cov.:
27
AF XY:
0.000326
AC XY:
24
AN XY:
73714
show subpopulations
African (AFR)
AF:
0.00117
AC:
48
AN:
41124
American (AMR)
AF:
0.000593
AC:
9
AN:
15184
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3458
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5056
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4752
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10440
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0000148
AC:
1
AN:
67670
Other (OTH)
AF:
0.000478
AC:
1
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000152
Hom.:
0
ESP6500AA
AF:
0.000525
AC:
2
ESP6500EA
AF:
0.000122
AC:
1
ExAC
AF:
0.0000911
AC:
11

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 16, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 21, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 1;C5567650:Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Uncertain:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 720 of the DIAPH1 protein (p.Leu720Phe). This variant is present in population databases (rs200606811, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with DIAPH1-related conditions. ClinVar contains an entry for this variant (Variation ID: 450432). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Not Available". The phenylalanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Benign:1
Feb 28, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Leu720Phe in exon 16 of DIAPH1: This variant is not expected to have clinical significance due to a lack of conservation across species, including mammals. Of note,4 mammals (rat, mouse, Tibetan antelope, and shrew) have a phenylalanine ( Phe) at this position despite high nearby amino acid conservation. In addition, computational prediction tools do not suggest a high likelihood of impact to the protein. It has been identified in 5/6746 Latino chromosomes and 4/7384 African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitu te.org; dbSNP rs200606811). -

Inborn genetic diseases Benign:1
Jul 21, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.14
T;.;T;.;T;.
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.38
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.66
T;T;T;T;T;T
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.039
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N;.;.;.;.;.
PhyloP100
0.97
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.3
N;.;.;N;N;N
REVEL
Benign
0.070
Sift
Benign
0.28
T;.;.;T;T;T
Sift4G
Benign
0.13
T;.;T;T;T;T
Polyphen
0.012
B;.;.;.;.;.
Vest4
0.24
MVP
0.67
MPC
0.12
ClinPred
0.011
T
GERP RS
2.5
Varity_R
0.074
gMVP
0.038
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200606811; hg19: chr5-140953259; API